GlassScriptPhysician profile
Francesco Rotatori
NPI 1902127814
$37,119.44
in general payments reported to CMS, 2019-2025
40 companies · $4,334 in 2025
The $4,334 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $2,502 · 2021: $10K · 2022: $4,038 · 2023: $8,339 · 2024: $6,883 · 2025: $4,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $4,175 · Education: $96.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,284.25 |
| Food and Beverage | $4,174.60 |
| Education | $96.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30,085.89 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,056.16 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $654.91 | 2019-2025 | Farxiga |
| Abiomed | $635.71 | 2020-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $620.55 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $481.28 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $466.27 | 2019-2020 | |
| Abbott Laboratories | $411.00 | 2021-2024 | Mitraclip, Cardiomems |
| Merck Sharp & Dohme LLC | $287.56 | 2022-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $280.32 | 2023-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.36 | 2020-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $214.42 | 2023-2025 | Amvuttra, Onpattro |
| Pfizer INC. | $202.65 | 2019-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $169.34 | 2024 | Arcalyst |
| Heartflow, INC. | $169.01 | 2022-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $146.60 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scpharmaceuticals INC. | $139.51 | 2025 | |
| Esperion Therapeutics, INC. | $139.18 | 2020-2024 | Nexletol |
| Medicomp INC | $89.34 | 2025 | Telepatch Cardiac Monitor |
| Medtronic, INC. | $87.87 | 2024-2025 | Cg Future, Ffrangio, Onyx Frontier |
| Shockwave Medical, INC | $69.89 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $61.69 | 2019-2025 | Kengreal |
| Bridgebio Pharma, INC. | $51.03 | 2025 | Attruby |
| Inspire Medical Systems, INC. | $46.12 | 2023-2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $44.09 | 2025 | |
| Boston Scientific Corporation | $33.03 | 2020 | |
| Amarin Pharma, INC. | $32.55 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $24.76 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $24.60 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.66 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $23.49 | 2023 | Inpefa |
| Baxter Healthcare | $22.74 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $22.28 | 2025 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $15.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.84 | 2021 | |
| Abbvie INC. | $13.83 | 2021 | |
| Coala Life INC | $13.21 | 2022 | |
| Cardinal Health 200 LLC | $12.48 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $11.67 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesco Rotatori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.